BRIEF-Latigo Biotherapeutics Announces IPO Of Common Stock
Reuters2026/07/17 17:30July 17 (Reuters) - Latigo Biotherapeutics:
LATIGO BIOTHERAPEUTICS - ANNOUNCES INITIAL PUBLIC OFFERING OF COMMON STOCK - SEC FILING
LATIGO BIOTHERAPEUTICS - APPLIES TO LIST ON NASDAQ UNDER SYMBOL LTGO - SEC FILING
LATIGO BIOTHERAPEUTICS: GOLDMAN SACHS & CO. LLC, JEFFERIES, LEERINK PARTNERS, GUGGENHEIM SECURITIES ARE UNDERWRITERS TO IPO
Source text: [ID:n0001193125-26-307306]
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Global Energy Roundup: Market Talk
NASDAQ TRADE HALT CONTINUES <TALK.O> REASON NOT AVAILABLE AT 03:58 AM
NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:58 AM
NASDAQ TRADE HALT CONTINUES <YYAI.O> REASON NOT AVAILABLE AT 03:58 AM
Crypto prices
More
